In addition, linc01232 interacts with the splicing factor hnRNPA2/B1 and stabilises hnRNPA2/B1 by inhibiting hnRNPA2/B1 ubiquitination and degradation to promote the expression of its splicing target A-Raf full-length, thereby promoting pancreatic cancer [62]. Here, HNRNPA2B1 is linked to pancreatic neoplasm.